患有PCI与Impella-support患者的贫血的影响:来自PROTECT III研究的见解
Batla Falah1, Björn Redfors1,2,3, Duzhi Zhao1
1Clinical Trials Center, Cardiovascular Research Foundation, New York, NY, United States.
Frontiers in cardiovascular medicine
|August 2, 2024
概括
在接受高风险皮肤冠状动脉干预 (HRPCI) 和Impella支持的患者中,贫血很常见. 贫血独立地增加了主要心血管和脑血管不良事件 (MACCE) 和术后出血的风险.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 血液学 血液学 血液学
背景情况:
- 贫血在心血管疾病患者中很普遍,与不良结果有关.
- 关于贫血对高风险皮肤冠状动脉干预 (HRPCI) 的影响的数据有限.
研究的目的:
- 评估贫血对接受Impella支持HRPCI的患者的影响.
- 评估贫血与主要心血管和脑血管不良事件 (MACCE) 和出血之间的关联.
主要方法:
- 对从PROTECT III研究中接受Impella支持的HRPCI的患者进行分析.
- 根据世卫组织的标准,将患者分为没有贫血,轻度贫血和中度/重度贫血组.
- 在贫血组中,在30天和90天对MACCE和主要出血事件的比较.
主要成果:
- 37.9%的人没有贫血,43.4%有轻度贫血,18.7%有中度/重度贫血.
- 贫血与30天和90天 (p<0.05) 的MACCE比率显著增加有关.
- 大型出血事件在贫血患者中也更频繁 (p=0.002).
结论:
- 基线贫血是IMPELLA支持HRPCI中MACCE和大出血的常见和独立预测因素.
- 贫血作为预后因素的重要性需要进一步调查.
- 在HRPCI后制定减轻贫血相关风险的策略至关重要.
相关概念视频
Cardiac Catheterization II: Right Heart Catheterization
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Peritoneal Dialysis III: Nursing Management
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...


